Cite
APA Citation
Beyazit, F., Beyazit, Y., Tanoglu, A., & Haznedaroglu, I. C. (2020). ankaferd hemostat (ABS) as a potential mucosal topical agent for the management of COVID-19 syndrome based on its PAR-1 inhibitory effect and oestrogen content. Medical hypotheses, 143, . http://access.bl.uk/ark:/81055/vdc_100110822126.0x000042